Plainfield, New Jersey Clinical Trials

A listing of Plainfield, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

The purpose of this additional part of the study is to test whether the study drug, nivolumab, is a safe treatment that will prevent participants' primary central nervous system lymphoma (PCNSL) from growing again (recurrence). Participants will be people with PCNSL who continue to have cell free tumor DNA (cfDNA) …

international normalized ratio
gilbert's syndrome
blood transfusion
aptt
ffpe
Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities)
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

flortaucipir
alzheimer's disease
florbetapir
positron emission tomography
mini-mental state examination
The Cognitive and Research Center of NJ
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Study researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a safe and effective treatment for …

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
 (9.4 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +6 other locations
T1

tt

Site Test 1
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

This phase II trial compares high-dose rate brachytherapy and stereotactic ablative radiotherapy as monotherapy in treating patients with prostate cancer that has not spread to other parts of the body (localized). High-dose rate brachytherapy delivers radiation directly into the prostate within a few minutes by a single radioactive seed through …

stage iia prostate cancer ajcc v8
stereotactic ablative radiotherapy
adenocarcinoma
stage iib prostate cancer ajcc v8
MRI
Rutgers Cancer Institute of New Jersey
 (6.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

epidermal growth factor
solid tumor
epidermal growth factor receptor
pembrolizumab
lymphoma
Overlook Medical Center /ID# 219108
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

The investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dose and volume of radiation therapy to control soft tissue sarcoma after surgery. They also want to find …

sarcoma of the extremity
serum pregnancy test
primary tumor
soft tissue sarcoma
sarcoma
Memoral Sloan Kettering Basking Ridge (All protocol activities)
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

nasogastric tube
seizure disorder
nervous system disorder
blood transfusion
cns involvement
Saint Peter's University Hospital
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given …

targeted therapy
thyroid cancer, follicular
absolute neutrophil count
measurable disease
vemurafenib
Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities)
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

aortic valve replacement
regurgitation
fatigue
shortness of breath
Rutgers State University
 (5.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations